Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Droste, a; Schmidt, M
Mammakarzinom: Aktuelle Strategien im fortgeschrittenen StadiumÄrztliches Journal Onkologie. Bd. 4. 2022 S. 18-22
Trocchi, P.; Swart, E.; Aleshchenko, E. et al.
Merging Data from the German Childhood Cancer Registry (DKKR) with Routine Data from Statutory Health Insurance Companies: methodological Aspects from the VersKiK StudyGESUNDHEITSWESEN. Bd. 84. H. 08/09. 2022 S. 728-728
Krajnak, S.; Anic, K.; Almstedt, K. et al.
Metronomic Chemotherapy as a Treatment Option for metastatic Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E109-E109
Erdmann, Friederike; Wellbrock, Maike; Borkhardt, Arndt et al.
MORE CHILDHOOD CANCER DIAGNOSES THAN EXPECTED: INCIDENCE, TIME OF DIAGNOSIS AND DELIVERY OF HEALTHCARE AMONG CHILDREN WITH CANCER IN GERMANY DURING THE COVID-19 PANDEMICPEDIATRIC BLOOD & CANCER. Bd. 69. 2022
Roemer, Tristan; Franzen, Sabrina; Kravets, Hanna et al.
Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim CohortCANCERS. Bd. 14. H. 5. 2022
Schmidt, M
Neutropenien bei Tumortherapie – aktuelle Aspekte.Trillium Krebsmedizin. Bd. 31. H. 5. 2022 S. 376-379
Haist, Maximilian; Ries, Frederic; Gunzer, Matthias et al.
Neutrophil-Specific Knockdown of beta 2 Integrins Impairs Antifungal Effector Functions and Aggravates the Course of Invasive Pulmonal AspergillosisFRONTIERS IN IMMUNOLOGY. Bd. 13. 2022
Decker, Thomas; Schmidt, Marcus
New Opportunities in Advanced Breast CancerONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. 1-2. 2022 S. 1-2
Huber, Yvonne; Foerster, Friedrich; Moehler, Markus et al.
New Studies at the University Medical Center Mainz on HCC and non-metastatic Colon CarcinomaGASTROENTEROLOGE. Bd. 17. H. 1. 2022 S. 57-58
Leinert, Elena; Schwentner, Lukas; Janni, Wolfgang et al.
Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II studyBREAST CANCER. Bd. 29. H. 3. 2022 S. 429-436